The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
Year: 2018
Type: review
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-179934
Authors: Ratan V. Bhat, Ulf Andersson, Shalini Andersson, Laurent Knerr, Udo Bauer, Anna K. Sundgren-Andersson
Institutions: AstraZeneca (Sweden), AstraZeneca (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keyword: GSK-3 inhibitors
Open Access status: closed
OpenAlex ID: W2802853266
